With the FDA expected to soon issue emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine for children aged 5 to 11, 55% of parents of children younger than 12 say they would plan to have their child receive it, while 45% would not. These figures have not wavered in monthly readings since May.